Tentative novel mechanism of the bystander effect in glioma gene therapy with HSV-TK/GCV system

被引:27
作者
Bai, SC
Du, LP
Liu, WQ
Whittle, IR
He, L
机构
[1] Chinese Acad Sci, Shanghai Inst Physiol, Shanghai 20031, Peoples R China
[2] Chinese Acad Sci, Shanghai Res Ctr Life Sci, Shanghai 20031, Peoples R China
[3] Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland
基金
中国国家自然科学基金;
关键词
D O I
10.1006/bbrc.1999.0766
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although many works support gap junctional intercellular communication (GJIC) having a close relation to bystander cell killing in herpes simplex virus thymidine kinase (HSV-TK) gene and ganciclovir (GCV) treatment, our previous work suggested that other factors involved in bystander effect besides GJIC exist. To confirm our primary work, we evaluated the mode of the bystander cell (C6) co-cultured with TK-positive cells (TF10.2) in our designed "insert plates" in which two cell lines could be separated but share the same medium, Another method that we used was adding the supernatant from the medium of GCV-treated TF10.2 cells to the wild type C6. Growth inhibition of the bystander cells was observed despite the absence of GJIC. In addition, apoptotic cell death of TK+ cells and bystander cells was obvious. These studies suggested that other pathways: besides cell-cell contacts may play a role in bystander cell killing; the factors released from TK-positive cells could induce apoptosis of bystander cells. (C) 1999 Academic Press.
引用
收藏
页码:455 / 459
页数:5
相关论文
共 21 条
[1]   Differential ganciclovir-mediated cytotoxicity and bystander killing in human colon carcinoma cell lines expressing herpes simplex virus thymidine kinase [J].
Boucher, PD ;
Ruch, RJ ;
Shewach, DS .
HUMAN GENE THERAPY, 1998, 9 (06) :801-814
[2]   Cancer gene therapy by direct tumor injections of a nonviral T7 vector encoding a thymidine kinase gene [J].
Chen, XZ ;
Li, YS ;
Xiong, KY ;
Aizicovici, S ;
Xie, YF ;
Zhu, Q ;
Sturtz, F ;
Shulok, J ;
Snodgrass, R ;
Wagner, TE ;
Platika, D .
HUMAN GENE THERAPY, 1998, 9 (05) :729-736
[3]   INVIVO GENE-TRANSFER WITH RETROVIRAL VECTOR PRODUCER CELLS FOR TREATMENT OF EXPERIMENTAL BRAIN-TUMORS [J].
CULVER, KW ;
RAM, Z ;
WALLBRIDGE, S ;
ISHII, H ;
OLDFIELD, EH ;
BLAESE, RM .
SCIENCE, 1992, 256 (5063) :1550-1552
[4]  
Dilber MS, 1997, CANCER RES, V57, P1523
[5]   FLOW CYTOMETRIC MEASUREMENT OF TOTAL DNA CONTENT AND INCORPORATED BROMODEOXYURIDINE [J].
DOLBEARE, F ;
GRATZNER, H ;
PALLAVICINI, MG ;
GRAY, JW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (18) :5573-5577
[6]  
Du LP, 1998, ADV EXP MED BIOL, V451, P133
[7]   Long-term connexin-mediated bystander effect in highly tumorigenic human cells in vivo in herpes simplex virus thymidine kinase ganciclovir gene therapy [J].
Duflot-Dancer, A ;
Piccoli, C ;
Rolland, A ;
Yamasaki, H ;
Mesnil, M .
GENE THERAPY, 1998, 5 (10) :1372-1378
[8]  
Hamel W, 1996, CANCER RES, V56, P2697
[9]   Bystander tumoricidal effect and gap junctional communication in lung cancer cell lines [J].
Imaizumi, K ;
Hasegawa, Y ;
Kawabe, T ;
Emi, N ;
Saito, H ;
Naruse, K ;
Shimokata, K .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1998, 18 (02) :205-212
[10]   GENE-THERAPY OF HEPATOMA - BYSTANDER EFFECTS AND NON-APOPTOTIC CELL-DEATH INDUCED BY THYMIDINE KINASE AND GANCICLOVIR [J].
KANEKO, Y ;
TSUKAMOTO, A .
CANCER LETTERS, 1995, 96 (01) :105-110